NPPA Revises Prices of 543 Anti-Cancer Medicine Brands, New Rates Effective November 9
The National Pharmaceutical Pricing Authority (NPPA) has announced revised maximum retail prices (MRPs) for 543 brands of anti-cancer medicines following…
National Pharmaceutical Pricing Authority
Read More
Supreme Court Questions High Medicine Markups, Criticises Centre Over Drug Pricing Regulation
The Supreme Court has raised serious concerns over substantial differences between the purchase prices and maximum retail prices (MRPs) of…
Cancer Treatment May Become More Affordable as NPPA Caps Trade Margins on 137 Drugs
Revised prices to take effect from November 9, 2026; MRPs of selected anti-cancer medicines expected to fall by up to…
Karnataka FDA Mandates Disclosure of Medicine and Medical Device Procurement Costs on Hospital Bills from November 1
The Karnataka Food Safety and Drug Administration (FDA) has directed hospitals, pharmacies and medical suppliers across the state to disclose…
Centre Seeks NPPA Review Over Wide Price Gaps in Hospital Consumables
The Centre has asked the National Pharmaceutical Pricing Authority (NPPA) to examine large differences between procurement prices and printed MRPs…
Hospital Consumables Under Scanner as Maharashtra FDA Flags Huge MRP Gaps
Maharashtra FDA Commissioner Tukaram Mundhe has raised concerns over large differences between the procurement prices and printed MRPs of medical…
Govt Waives Re-labelling of Medicines After GST Cut
Pharmaceutical companies will not have to recall or re-label medicines already available in the market before September 22, 2025, despite…
CDSCO Grants 3-Month Period for Medical Device Firms to Revise MRP Amid GST Rate Cut
The Central Drugs Standard Control Organisation (CDSCO) on Thursday (September 11) directed medical device manufacturers and importers to update their…
Cardiac Stent Prices to Rise by 2% Following Regulator’s Approval
The cost of cardiac stents in India is set to increase by nearly 2% after the country’s drug pricing regulator…